Results 61 to 70 of about 34,514 (296)

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

ESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller, Tobias Harm, Manuel Sigle, Parwez Aidery, Klaus‐Peter Kreisselmeier, Livia Baas, Andreas Goldschmied, Meinrad Paul Gawaz, Karin Anne Lydia Müller   +8 more
wiley   +1 more source

Implementation of guideline‐recommended medical therapy for patients with heart failure in Europe

ESC Heart Failure, Volume 12, Issue 2, Page 790-798, April 2025.
Abstract Physicians' adherence to guideline‐recommended heart failure (HF) treatment remains suboptimal, especially regarding the target doses. In particular, there is evidence that non‐cardiologists are less compliant with HF guideline recommendations. This is likely to have a detrimental impact on patients' survival, readmissions and quality of life.
Maurizio Volterrani, Petar Seferovic, Gianluigi Savarese, Ilaria Spoletini, Egidio Imbalzano, Antoni Bayes‐Genis, Ewa Jankowska, Michele Senni, Marco Metra, Ovidiu Chioncel, Andrew J. S. Coats, Giuseppe M. C. Rosano   +11 more
wiley   +1 more source

Living With Implantable Cardioverter Defibrillator: A phenomenological Study

حیات, 2014
Background & Aim: Implantable Cardioverter Defibrillator is the most effective treatment for cardiac dysrhythmias. Having such life-saving device is the unique experience with important changes in the patient’ life. Understanding of these experiences can
Mohammad Abbasi, Reza Negarandeh, Nahid Dehghan Nayeri   +2 more
doaj   +2 more sources

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Role of Implantable Cardioverter Defibrillators in the Treatment of Hypertrophic Cardiomyopathy [PDF]

, 2005
Hypertrophic cardiomyopathy (HCM) is an important cardiovascular disease with sudden cardiac death as the most devastating presentation. Implantable cardioverter defibrillators (ICD) are the optimal therapy for prevention of sudden death from ventricular
Maron, Barry J., Barry J. Maron, Johnson Francis, Francis, Johnson, Ghosh, Joydeep, Joydeep Ghosh   +5 more
core  

Implantable cardioverter defibrillator knowledge and end-of-life device deactivation: A cross-sectional survey

, 2017
Background: End-of-life implantable cardioverter defibrillator deactivation discussions should commence before device implantation and be ongoing, yet many implantable cardioverter defibrillators remain active in patients’ last days.
Debra K Moser, Chantal F Ski, Justin A Mariani, Jennifer Miller, Lee, Kyoung Suk, Lugg, Eugene, Ski, Chantal F., Haedtke, Chris, Moser, Debra K., Martha J Biddle, Mariani, Justin A., Cameron, Jan, David R Thompson, Chung, Misook Lee, Samantha M McEvedy, Hammash, Muna, Jan Cameron, Eugene Lugg, Muna Hammash, Thompson, David R.; id_orcid, McEvedy, Samantha M., Miller, Jennifer, Kyoung Suk Lee, Biddle, Martha J., Chris Haedtke, Misook Lee Chung   +25 more
core   +1 more source

Phenotyping patients with chronic obstructive pulmonary disease and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 900-911, April 2025.
Central illustration. Abbreviations: ACEi, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNi, angiotensin‐receptor‐neprilysin inhibitor; CI, confidence interval; COPD, chronic obstructive pulmonary disease; CRT, cardiac resynchronization therapy; CV, cardiovascular; EF, ejection fraction; eGFR, estimated glomerular ...
Peter Moritz Becher, Felix Lindberg, Lina Benson, Camilla Hage, Ulf Dahlström, Stephan Rosenkranz, Francesco Cosentino, Giuseppe M.C. Rosano, Stefan Blankenberg, Paulus Kirchhof, Frieder Braunschweig, Lars H. Lund, Gianluigi Savarese   +12 more
wiley   +1 more source

Determinants and trajectory of phobic anxiety in patients living with an implantable cardioverter defibrillator

, 2011
The implantable cardioverter defibrillator (ICD) is the gold standard therapy to prevent life-threatening arrhythmias. Phobic anxiety predicts ventricular arrhythmia in coronary heart disease patients, but little is known about phobic anxiety in ICD ...
Cho, En-Young Nicole, von Känel, R., Marten-Mittag, B., Kolb, C., Ladwig, Karl-Heinz, Ronel, J., Ladwig, K.-H., Baumert, J., Kolb, Christof, Marten-Mittag, Birgit, Baumert, Jens, Cho, E.Y., Ladwig, K. H., von Känel, Roland, Baumert, J.J., Cho, EN-Y, Ronel, Joram   +16 more
core   +1 more source

Comparative performance of risk prediction indices for mortality or readmission following heart failure hospitalization

ESC Heart Failure, Volume 12, Issue 2, Page 1227-1236, April 2025.
Comparative performance of 7 risk prediction indices in patients hospitalized for heart failure. In this cohort of 1206 patients, the LENT index offered the greatest discrimination, calibration, and overall accuracy in predicting 30‐day composite all‐cause mortality or readmission following hospitalization for heart failure.
Tauben Averbuch, Ali Zafari, Shofiqul Islam, Shun Fu Lee, Rajiv Sankaranarayanan, Stephen J Greene, Mamas A Mamas, Ambarish Pandey, Harriette GC Van Spall   +8 more
wiley   +1 more source

Single-Pocket-Incision Generator Exchange From a Subcutaneous to an Extravascular Implantable Cardioverter-Defibrillator. [PDF]

J Arrhythm
Subcutaneous‐to‐extravascular implantable cardioverter‐defibrillator exchange can create a practical challenge: the existing subcutaneous generator pocket lies posteriorly, whereas the new extravascular generator site is planned more anteriorly. In this case, fluoroscopic planning showed adjacent generator sites, allowing a single intervening pocket ...
Onishi Y, Chino S, Kurata M, Iso Y, Suzuki H.   +4 more
europepmc   +2 more sources